| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/16/2000 | EP0979081A1 Composition and methods using an eutomer |
| 02/16/2000 | EP0979077A1 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders |
| 02/16/2000 | EP0979073A1 Nitrosylation to inactivate apoptotic enzymes |
| 02/16/2000 | EP0979069A1 Method for producing orally administered, solid pharmaceutical products with controlled release of the active substance |
| 02/16/2000 | CN1244870A Tissue specific expression of retinoblastoma protein |
| 02/16/2000 | CN1244867A Substitued nitrogen containing heterocycles as inhibitors of P38 protein kinase |
| 02/16/2000 | CN1244864A 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists |
| 02/16/2000 | CN1244862A Endothelin antagonists: N-[[2'-[[4,5-dimethyl-3-isoxazolyl) amino] sulfonyl]-4-(2-oxazolyl) [1,1'-biphenyl]-2-yl] methyl] |
| 02/16/2000 | CN1244859A Benzenesulfonamide derivatives and drugs containing the same |
| 02/16/2000 | CN1244772A Targeted cytotoxic cell |
| 02/16/2000 | CN1244528A Di- Or triaza-spiral [4,5] decane derivative |
| 02/16/2000 | CN1244526A Effective synthetic method for furau sulfonic acid amide compound for synthesizing new IL-1 inhibitor |
| 02/16/2000 | CN1244429A Hedgelog protein medicinal composition and its use |
| 02/16/2000 | CN1244420A Health-giving oral liquor |
| 02/16/2000 | CN1244407A Americum ginseng tea and its preparation process |
| 02/16/2000 | CN1049434C Aromatic amidine derivatives and method for preparing medicinal salts thereof |
| 02/16/2000 | CN1049430C Sulfonamides and its preparing method and use thereof |
| 02/16/2000 | CN1049357C Treatment of human viral infection by ds RNA combined with viral inhibitors |
| 02/16/2000 | CN1049336C Isoxazole derivatives for the treatment of irritable bowels system in preparing composition |
| 02/16/2000 | CN1049334C New use of fatty acid medicine |
| 02/16/2000 | CN1049333C Process for producing fine particulate materials |
| 02/15/2000 | US6025507 Borneol derivatives, methods of manufacturing them, and their pharmaceutical use |
| 02/15/2000 | US6025500 Heterogeneous catalytic reductive amination between alanylproline and ethyl-2-oxo-4-phenylbutyrate |
| 02/15/2000 | US6025494 Tetracyclic derivatives, process of preparation and use |
| 02/15/2000 | US6025468 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic LHRH peptides |
| 02/15/2000 | US6025465 Insulin-like growth factor binding protein (IGFBP-6) |
| 02/15/2000 | US6025398 Benzamidoxime prodrugs as antipneumocystic agents |
| 02/15/2000 | US6025396 Stable prostaglandin E1-containing injectable composition |
| 02/15/2000 | US6025392 substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
| 02/15/2000 | US6025388 Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids |
| 02/15/2000 | US6025387 Gastroprotective flavone/flavanone compounds with therapeutic effect on inflammatory bowel disease |
| 02/15/2000 | US6025374 Migraine |
| 02/15/2000 | US6025372 Somatostatin agonists |
| 02/15/2000 | US6025365 Chelerythrine and radiation combined tumor therapy |
| 02/15/2000 | US6025361 Effective pde iv inhibitors, asthma |
| 02/15/2000 | US6025356 Powerful dopaminergic compounds, low level of side effects exhibited. |
| 02/15/2000 | US6025354 Exhibit phosphodiesterase iv inhibition and can be used to treat asthmatic disorders. |
| 02/15/2000 | US6025344 Certain dioic acid derivatives useful as NAALADase inhibitors |
| 02/15/2000 | US6025340 Surface expression of enzyme in gene directed prodrug therapy |
| 02/15/2000 | US6025332 Method for treating low circulating levels of sex hormone steroids associated with aging using IGF or IGF/IGFBP-3 |
| 02/15/2000 | US6025331 Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis |
| 02/15/2000 | US6025198 Antisense modulation of Ship-2 expression |
| 02/15/2000 | US6025197 Secreted salivary zsig32 polypeptides |
| 02/15/2000 | US6025147 Inhibitors of interleukin-1 β converting enzyme |
| 02/15/2000 | US6025142 Hydrophobic u-PAR binding site |
| 02/15/2000 | US6024984 Composition containing an extract from muirapuama root and plant worm extract |
| 02/15/2000 | US6024977 Covalent polar lipid conjugates with neurologically active compounds for targeting |
| 02/15/2000 | US6024960 Rose-hip formulations as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and arthritis |
| 02/15/2000 | US6024940 Antiinflammatory agents for mammals |
| 02/15/2000 | US6024936 Antibody-based method of localizing activated thrombin receptors |
| 02/15/2000 | CA2197739C 1,4-dihydropyridine compounds |
| 02/15/2000 | CA2154730C Synergetic blend compositions between at least one rxr specific ligand and at least one rar- specific ligand; uses thereof |
| 02/15/2000 | CA2152792C Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents |
| 02/15/2000 | CA2119218C Enantioselective synthesis of 5,6-dihydro-(s)-4-(ethylamino)-(s)-6-methyl-4h-thieno 2,3-b thiopyran-2-sulfonamide 7,7-dioxide and related compounds |
| 02/15/2000 | CA2015994C Human lactoferrin cdna sequence |
| 02/10/2000 | WO2000007014A2 Leptin-mediated gene-induction |
| 02/10/2000 | WO2000006768A1 Genetic polymorphisms in the human neurokinin 1 receptor gene and their uses in diagnosis and treatment of diseases |
| 02/10/2000 | WO2000006767A1 Genetic polymorphisms in the human neurokinin 2 receptor gene and their use in diagnosis and treatment of diseases |
| 02/10/2000 | WO2000006730A2 Human cytoskeletal proteins |
| 02/10/2000 | WO2000006712A2 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof |
| 02/10/2000 | WO2000006709A1 Human protein kinase h2lau20 |
| 02/10/2000 | WO2000006705A2 Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy |
| 02/10/2000 | WO2000006703A2 Inhibition of graft versus host disease |
| 02/10/2000 | WO2000006601A1 Isoforms of human calcium sensing receptor |
| 02/10/2000 | WO2000006597A2 Endogenous constitutively activated g protein-coupled orphan receptors |
| 02/10/2000 | WO2000006589A1 Prostate derived ets factor |
| 02/10/2000 | WO2000006587A1 New cofactors for methyltransferases |
| 02/10/2000 | WO2000006580A1 Pyridobenzothiazine derivatives and process for producing the same |
| 02/10/2000 | WO2000006578A1 Pyridobenzoxazine derivatives and process for producing the same |
| 02/10/2000 | WO2000006572A1 Bensoquinolizine derivatives and process for producing the same |
| 02/10/2000 | WO2000006571A1 Pyrroloquinoline derivatives and process for producing the same |
| 02/10/2000 | WO2000006569A1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
| 02/10/2000 | WO2000006567A1 3-(4-amino-5-ethylpyrimidine-2-yl)-1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridine |
| 02/10/2000 | WO2000006561A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 02/10/2000 | WO2000006555A1 Substituted quinazoline derivatives |
| 02/10/2000 | WO2000006544A1 Cyclic amine derivatives and process for the preparation thereof |
| 02/10/2000 | WO2000006529A1 Diketoacid-derivatives as inhibitors of polymerases |
| 02/10/2000 | WO2000006254A2 Non-imidazole alkylamines as histamine h3-receptor ligands and their therapeutic applications |
| 02/10/2000 | WO2000006187A2 Modulation of apoptosis |
| 02/10/2000 | WO2000006183A1 C7F2-A NOVEL POTASSIUM CHANNEL β-SUBUNIT |
| 02/10/2000 | WO2000006159A1 Heterocyclic sulphonamide derivatives |
| 02/10/2000 | WO2000006158A1 Heterocyclyl sulphonamide derivatives |
| 02/10/2000 | WO2000006157A1 Sulphonamide derivatives |
| 02/10/2000 | WO2000006156A1 Amide, carbamate, and urea derivatives |
| 02/10/2000 | WO2000006149A1 Sulfonamide derivatives |
| 02/10/2000 | WO2000006148A1 Sulphonamide derivatives |
| 02/10/2000 | WO2000006147A1 Macrophage scavenger receptor antagonists |
| 02/10/2000 | WO2000006145A1 Methods for treating conditions modulated by lactosylceramide |
| 02/10/2000 | WO2000006142A1 Injectable propofol formulations |
| 02/10/2000 | WO2000006140A2 Use of moclobemide for treating certain phsychiatric and medical disorders |
| 02/10/2000 | WO2000006135A2 Cholinergic agents in the treatment of presbyopia |
| 02/10/2000 | WO2000006032A1 Ultrasonic enhancement of drug injection |
| 02/10/2000 | WO2000000489A3 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands |
| 02/10/2000 | WO1999067254A3 Multi-drug resistant retroviral protease inhibitors and use thereof |
| 02/10/2000 | WO1999065936A3 Composition for the treatement of immune deficiencies and methods for its preparation and use |
| 02/10/2000 | WO1999063944A3 Novel therapeutic agents that modulate estrogen receptors |
| 02/10/2000 | WO1999063939A3 Multibinding inhibitors of cyclooxygenase-2 |
| 02/10/2000 | WO1999062526A3 Use of genetically engineered antibodies to cd38 to treat multiple myeloma |
| 02/10/2000 | WO1999061600A3 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 02/10/2000 | WO1999058674A3 Method of inhibiting osteoclast activity |